Recently Viewed
Clear All
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,754 Cr
P/E Ratio
20.93
P/B Ratio
1.67
Industry P/E
32.09
Debt to Equity
0.02
ROE
6.46 %
ROCE
8.72 %
Div. Yield
0.81 %
Book Value
743.86
EPS
48.46
CFO
₹268.72 Cr
EBITDA
₹338.72 Cr
Net Profit
₹275.22 Cr
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
TTK Healthcare
| -11.54 | 12.73 | -6.63 | -18.98 | 16.70 | 21.53 | -- |
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
---|---|---|---|---|---|---|---|
TTK Healthcare
| 1.43 | 40.85 | 42.38 | 21.36 | 20.60 | -39.63 | -3.63 |
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
---|---|---|---|---|
733.60 | 6,652.58 | 26.68 | 13.8 | |
2,322.20 | 9,511.53 | 78.36 | 12.96 | |
431.60 | 5,319.81 | 71.34 | 6.24 | |
913.20 | 5,216.91 | 40.95 | 14.76 |
1 min read•By Research Desk
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices,... Protective Devices, Foods, Human Pharma, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, anti-parasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripewater name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Human Pharma is involved in the development and commercialization of such as gynecology, infertility, respiratory, orthopedics, cardiology, and general health therapeutic needs. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd. Read more
Incorporated
1958
Chairman
T T Raghunathan
Managing Director
--
Group
TTK
Headquarters
Chennai, Tamil Nadu
Website
Looking for more details about TTK Healthcare Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
Announcements
View AnnouncementsOutcome Of Board Meeting - March 21 2025
21-Mar-2025Outcome Of The Board Meeting - March 21 2025
21-Mar-2025The total asset value of TTK Healthcare Ltd stood at ₹ 1,267 Cr as on 31-Dec-24
The share price of TTK Healthcare Ltd is ₹1,245.10 (NSE) and ₹1,241.25 (BSE) as of 17-Apr-2025 IST. TTK Healthcare Ltd has given a return of 16.7% in the last 3 years.
TTK Healthcare Ltd has a market capitalisation of ₹ 1,754 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of TTK Healthcare Ltd is 1.67 times as on 17-Apr-2025, a 55% discount to its peers’ median range of 3.70 times.
The P/E ratio of TTK Healthcare Ltd is 20.93 times as on 17-Apr-2025, a 35% discount to its peers’ median range of 32.09 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the TTK Healthcare Ltd and enter the required number of quantities and click on buy to purchase the shares of TTK Healthcare Ltd.
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, Human Pharma, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, anti-parasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripewater name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Human Pharma is involved in the development and commercialization of such as gynecology, infertility, respiratory, orthopedics, cardiology, and general health therapeutic needs. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.
The promoters of TTK Healthcare Ltd are T T KRISHNAMACHARI & CO. represented by its Partners - Mr T T Jagannathan and Mr T T Raghunathan and THIRUVALLUR THATTAI JAGANNATHAN. They collectively own 72.83 per cent of the total equity. The chairman of the company is T T Raghunathan
There is no promoter pledging in TTK Healthcare Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
9,512
|
|
6,653
|
|
5,320
|
|
5,217
|
TTK Healthcare Ltd. | Ratios |
---|---|
Return on equity(%)
|
6.71
|
Operating margin(%)
|
3.25
|
Net Margin(%)
|
9.73
|
Dividend yield(%)
|
0.81
|
Yes, TTM profit after tax of TTK Healthcare Ltd was ₹84 Cr.